+49.9%
GDX vs GSK
+24.6%
+25.3%
-38.9%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | GSK | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.1% | +0.2% | +0.9% | +1.0% |
| 7D | +1.9% | -3.6% | +5.5% | +2.9% |
| 30D | +9.9% | -5.9% | +15.8% | +11.6% |
| 3M | +28.2% | -4.3% | +32.5% | +29.4% |
| 6M | -2.9% | -10.8% | +7.9% | -0.5% |
| YTD | +16.0% | +1.8% | +14.2% | +17.9% |
| 1Y | +49.9% | +23.5% | +26.4% | +47.2% |
| All | +49.9% | +24.6% | +25.3% | +47.2% |
Cumulative growth
Daily Returns
Daily percentage return beside GSK.
Daily Out/Under-Performance
Portfolio return minus GSK return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling